dactinomycin and vasoactive intestinal peptide

dactinomycin has been researched along with vasoactive intestinal peptide in 12 studies

Research

Studies (12)

TimeframeStudies, this research(%)All Research%
pre-19904 (33.33)18.7374
1990's7 (58.33)18.2507
2000's1 (8.33)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Enochs, MR; Johnson, LR1
Wiik, P1
Livett, BG; Wan, DC1
George, FW; Ojeda, SR1
Buchanan, KD; Cantwell, B; Collins, PG; Fennelly, JJ; Fielding, JF; FitzGerald, O1
Inoue, H; Koshihara, Y; Nagata, N1
Kurihara, K; Matsuoka, I; Nagao, H1
Buchanan, KD; Courtney, MG; Fielding, JF; Holloway, H; Lane, BE; Leavey, SF; Royston, D1
Davidson, A; Gozes, I; Moody, TW1
Anastasiadis, PZ; Bezin, L; Blitz, J; Gordon, LJ; Imerman, B; Kuhn, DM; Levine, RA1
El Halawani, ME; Foster, DN; Pitts, GR; Tong, Z; You, S1
Fahrenkrug, J; Georg, B; Madsen, B; Madsen, MW1

Reviews

3 review(s) available for dactinomycin and vasoactive intestinal peptide

ArticleYear
Trophic effects of gastrointestinal hormones: physiological implications.
    Federation proceedings, 1977, Volume: 36, Issue:7

    Topics: Animals; Cholecystokinin; Dactinomycin; DNA; Gastrectomy; Gastric Mucosa; Gastrins; Gastrointestinal Hormones; Growth Hormone; Intestinal Mucosa; Intestine, Small; Liver; Pancreas; Pentagastrin; Protein Biosynthesis; Secretin; Starvation; Vasoactive Intestinal Peptide

1977
Pancreatic vipomas: spectrum of presentation and evolution of diagnostic and therapeutic modalities.
    Irish journal of medical science, 1995, Volume: 164, Issue:1

    Topics: Combined Modality Therapy; Dactinomycin; Diagnosis, Differential; Female; Humans; Male; Middle Aged; Pancreatectomy; Pancreatic Neoplasms; Prednisolone; Vasoactive Intestinal Peptide; Vipoma

1995
Regulation of VIP gene expression in general. Human lung cancer cells in particular.
    Journal of molecular neuroscience : MN, 1996,Summer, Volume: 7, Issue:2

    Topics: Animals; Carcinoma, Non-Small-Cell Lung; Carcinoma, Small Cell; Cell Division; Colforsin; Cyclic AMP; Dactinomycin; Female; Gene Expression Regulation; Humans; Lung Neoplasms; Male; Neoplasm Proteins; Neurosecretory Systems; Nucleic Acid Synthesis Inhibitors; Organ Specificity; Rats; RNA, Messenger; RNA, Neoplasm; Tetradecanoylphorbol Acetate; Tumor Cells, Cultured; Vasoactive Intestinal Peptide

1996

Other Studies

9 other study(ies) available for dactinomycin and vasoactive intestinal peptide

ArticleYear
Glucocorticoids upregulate the high affinity receptors for vasoactive intestinal peptide (VIP) on human mononuclear leucocytes in vitro.
    Regulatory peptides, 1991, Jul-23, Volume: 35, Issue:1

    Topics: Cyclic AMP; Dactinomycin; Dexamethasone; Dose-Response Relationship, Drug; Humans; Hydrocortisone; Kinetics; Leukocytes, Mononuclear; Protein Synthesis Inhibitors; Receptors, Gastrointestinal Hormone; Receptors, Vasoactive Intestinal Peptide; Time Factors; Up-Regulation; Vasoactive Intestinal Peptide

1991
Vasoactive intestinal peptide stimulates proenkephalin A mRNA expression in bovine adrenal chromaffin cells.
    Neuroscience letters, 1989, Jun-19, Volume: 101, Issue:2

    Topics: Adrenal Medulla; Animals; Blotting, Northern; Cattle; Cells, Cultured; Dactinomycin; Enkephalins; Gallopamil; Hexamethonium Compounds; Protein Precursors; RNA, Messenger; Substance P; Vasoactive Intestinal Peptide

1989
Vasoactive intestinal peptide enhances aromatase activity in the neonatal rat ovary before development of primary follicles or responsiveness to follicle-stimulating hormone.
    Proceedings of the National Academy of Sciences of the United States of America, 1987, Volume: 84, Issue:16

    Topics: Animals; Aromatase; Bucladesine; Cycloheximide; Dactinomycin; Female; Follicle Stimulating Hormone; Luteinizing Hormone; Organ Culture Techniques; Ovarian Follicle; Ovary; Pregnancy; Rats; Rats, Inbred Strains; Testosterone; Vasoactive Intestinal Peptide

1987
Metastatic pancreatic vipoma: a case report of clinical response following treatment with corticosteroids and actinomycin D.
    Clinical oncology, 1982, Volume: 8, Issue:2

    Topics: Adenoma, Islet Cell; Dactinomycin; Female; Humans; Indomethacin; Liver Neoplasms; Middle Aged; Pancreatic Neoplasms; Prednisolone; Vasoactive Intestinal Peptide; Vipoma

1982
Inhibition by actinomycin D of neurogenic mouse ear oedema.
    Inflammation research : official journal of the European Histamine Research Society ... [et al.], 1995, Volume: 44, Issue:3

    Topics: Animals; Bradykinin; Calcimycin; Calcitonin Gene-Related Peptide; Capsaicin; Cycloheximide; Dactinomycin; Disease Models, Animal; Dose-Response Relationship, Drug; Doxorubicin; Ear Diseases; Edema; Histamine; Injections, Intravenous; Leukotriene C4; Male; Mast Cells; Mice; p-Methoxy-N-methylphenethylamine; Platelet Activating Factor; Rats; Rats, Wistar; Serotonin; Substance P; Tachykinins; Vasoactive Intestinal Peptide

1995
Effects of adenylyl cyclase-linked neuropeptides on the expression of ciliary neurotrophic factor-mRNA in cultured astrocytes.
    FEBS letters, 1995, Mar-27, Volume: 362, Issue:1

    Topics: Adenylyl Cyclases; Animals; Astrocytes; Cells, Cultured; Cerebral Cortex; Ciliary Neurotrophic Factor; Colforsin; Cyclic AMP; Cycloheximide; Dactinomycin; Dopamine; Isoproterenol; Nerve Tissue Proteins; Neuropeptides; Olfactory Bulb; Pituitary Adenylate Cyclase-Activating Polypeptide; Rats; RNA, Messenger; Transcription, Genetic; Vasoactive Intestinal Peptide

1995
Vasoactive intestinal peptide induces both tyrosine hydroxylase activity and tetrahydrobiopterin biosynthesis in PC12 cells.
    Neuroscience, 1998, Volume: 86, Issue:1

    Topics: Alcohol Oxidoreductases; Animals; Antioxidants; Biopterins; Catecholamines; Cyclic AMP; Dactinomycin; Enzyme Activation; Enzyme Induction; GTP Cyclohydrolase; Kinetics; PC12 Cells; Polymerase Chain Reaction; Protein Kinase C; Rats; RNA, Messenger; Second Messenger Systems; Tetradecanoylphorbol Acetate; Transcription, Genetic; Tyrosine 3-Monooxygenase; Vasoactive Intestinal Peptide

1998
Vasoactive intestinal peptide stimulates turkey prolactin gene expression by increasing transcription rate and enhancing mRNA stability.
    Journal of molecular endocrinology, 1998, Volume: 21, Issue:3

    Topics: Animals; Cells, Cultured; Dactinomycin; Drug Stability; Female; Gene Expression Regulation; Immunization; Kinetics; Pituitary Gland, Anterior; Prolactin; RNA Processing, Post-Transcriptional; RNA, Messenger; Transcription, Genetic; Turkeys; Vasoactive Intestinal Peptide

1998
Downregulation of VPAC1R expression in breast cancer cell lines.
    Annals of the New York Academy of Sciences, 2000, Volume: 921

    Topics: Breast; Breast Neoplasms; Dactinomycin; Down-Regulation; Estradiol; Estrogen Receptor Modulators; Female; Humans; Receptors, Vasoactive Intestinal Peptide; Receptors, Vasoactive Intestinal Polypeptide, Type I; RNA, Messenger; RNA, Neoplasm; Transcription, Genetic; Transfection; Tumor Cells, Cultured; Vasoactive Intestinal Peptide

2000